Exelixis
EXEL
#1617
Rank
NZ$18.10 B
Marketcap
$64.70
Share price
-5.68%
Change (1 day)
77.76%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $86.29 NZD on 2000-07-26

Lowest end of day price: $2.26 NZD on 2014-12-24

Stock price history of Exelixis from 2000 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$69.20-2.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
$102.91-1.03%๐Ÿ‡ซ๐Ÿ‡ท France
$165.97-0.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$107.77-2.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$558.70-2.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$290.59-1.10%๐Ÿ‡บ๐Ÿ‡ธ USA
$45.53-2.44%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.66-4.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$26.28 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA